UnaVista SFTR closure casts doubt on viability of reg reporting

The decision to shutter the service is another blow to the industry and the business case of reg reporting under SFTR.

In late July, UnaVista, the regulatory reporting arm of London Stock Exchange Group, announced plans to close its Securities Financing Transactions Regulation (SFTR) service on January 31, 2022, making it the industry’s latest casualty in a battle with high running costs and wafer-thin margins.

The past two years have seen multiple providers in the regulatory reporting space roll back or offload their services—most notably Deutsche Börse’s sale of its Regulatory Reporting Hub to MarketAxess

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

‘Feature, not a bug’: Bloomberg makes the case for Figi

Bloomberg created the Figi identifier, but ceded all its rights to the Object Management Group 10 years ago. Here, Bloomberg’s Richard Robinson and Steve Meizanis write to dispel what they believe to be misconceptions about Figi and the FDTA.

Where have all the exchange platform providers gone?

The IMD Wrap: Running an exchange is a profitable business. The margins on market data sales alone can be staggering. And since every exchange needs a reliable and efficient exchange technology stack, Max asks why more vendors aren’t diving into this space.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here